Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 10 , ISSUE 2 ( April-June, 2018 ) > List of Articles

ORIGINAL ARTICLE

Comparative Evaluation of Diagnostic Efficacy of Serum Anti-Müllerian Hormone and Ultrasound in Polycystic Ovarian Syndrome

Ankita Kumari, Harish C Tiwari, Reena Srivastav

Keywords : Anti-Müllerian hormone, Body mass index, Ovarian volume, Polycystic ovarian syndrome, Waist–hip ratio

Citation Information : Kumari A, Tiwari HC, Srivastav R. Comparative Evaluation of Diagnostic Efficacy of Serum Anti-Müllerian Hormone and Ultrasound in Polycystic Ovarian Syndrome. J South Asian Feder Obs Gynae 2018; 10 (2):98-103.

DOI: 10.5005/jp-journals-10006-1569

Published Online: 01-01-2017

Copyright Statement:  Copyright © 2018; The Author(s).


Abstract

Aim: To study the diagnostic efficacy of serum anti-Müllerian hormone (AMH) in polycystic ovarian syndrome (PCOS) and its comparison with ultrasonography (USG). Study design: Prospective observational study. Materials and methods: In the study group, a total of 80 women in the age group of 20 to 35 years with diagnosis of PCOS by Rotterdam's criteria were recruited at B.R.D. Medical College, Gorakhpur, India, during the period from January 2015 to December 2016. Women without PCOS, having regular cycles which were selected randomly comprised the control group (n = 80). Serum levels of luteinizing hormone (LH), folliclestimulating hormone (FSH), testosterone, androstenedione, estradiol, fasting insulin, and AMH were measured on days 2 to 3 of natural cycle or progesterone-induced withdrawal bleeding together with transvaginal sonography (TVS) for detection of the number of small follicles (<10 mm) and measurement of ovarian volume (OV). The AMH levels above 5 ng/mL were taken as diagnostic cut-off for diagnosing PCOS. Results: Anti-Müllerian hormone was positively correlated to LH, estradiol, testosterone, number of follicles (<10 mm), and OV; and negatively correlated to FSH. No correlation was found between AMH and age, body mass index (BMI), waist–hip ratio (WHR), and fasting insulin. The AMH-based diagnosis of PCOS showed sensitivity of 91.25% and a specificity of 95%. Conclusion: Serum AMH level is a promising marker for diagnosis of PCOS, especially in cases where reliable USG data are not available or when there are no typical clinical and laboratory findings.


PDF Share
  1. Moran C, Tena G, Moran S, Ruiz P, Reyna R, Duque X. Prevalence of polycystic ovary syndrome and related disorders in women. Gynecol Obstet Invest 2010;69(4):274-280.
  2. Swellam M, Khaial A, Mosa T, El-Baz H, Said M. Anti mullerian and androgen hormones in women with polycystic ovary syndrome undergoing IVF/ICSI. Iran J Reprod Med 2013 Nov;11(11):883-890.
  3. Usadi RS, Legro RS. Reproductive impact of polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes 2012 Dec;19(6):505-511.
  4. Burt Solorzano CM, Beller JP, Abshire MY, Collins JS, McCartney CR, Marshall JC. Neuroendocrine dysfunction in polycystic ovary syndrome. Steroids 2012 Mar 10;77(4):332-337.
  5. Chun S. Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome. Clin Exp Reprod Med 2014;41(2):86-91.
  6. Haider S, Manan N, Khan A, Qureshi MA. Prevalence of elevated luteinizing hormone (LH)/follicle stimulating hormone (FSH) ratio in polycystic ovary syndrome (PCOS) women among local population. J Dow Univ Health Sci Karachi 2011;5(1):17-20.
  7. Ramprasad D, Shivli M, Ranu RB, Arunima M, Biswas SC. Association of metabolic syndrome in PCOS: an observational study. J Obstet Gynecol of India 2011 Mar/Apr:176-181.
  8. Nazir F, Sayeed S, Malik M, Aziz H, Rana SA. Polycystic ovarian syndrome—diagnosis and management in fertility deprivation. Pak J Obstet Gynecol 1999;12(1-2):59-71.
  9. Lim SS, Davis MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovarian syndrome: a systemic review and meta analysis. Hum Reprod Update 2012;18(6):618-637.
  10. Panda SR, Durgawati K, Sahu SK. A study of clinical parameters in the diagnosis of polycystic ovarian syndrome. J Evol Med Dent Sci 2014 Sep 8;3(42):10570-10579.
  11. Yousouf R, Khan M, Kounsar Z, Ahangar S, Lone WA. Polycystic ovarian syndrome clinical correlation with biochemical status. J Med Healthc 2012 May;3(5):245-248.
  12. Vignesh JP, Mohan V. Polycystic ovary syndrome: a component of metabolic syndrome? J Postgrad Med 2007;53:128-134.
  13. Leonte M, Coculescu S, Radian T, Fica A, Caragheogheopol A, Masecu B, Bohalte C, Grigorescu F. Antimullerian hormone as a useful marker in diagnosis of polycystic ovary syndrome. Acta Endocrinol 2007 Jan;3(1).
  14. Sadiq AM, Jarah DM. The relation of serum anti-mullerian hormone with polycystic ovary syndrome: correlation with clinical and hormonal parameters. J Nat Sci Res 2015;5(4): 10-14.
  15. Pingy P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S. Elevated serum levels of AMH in patients with PCOS: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metabol 2003;88(12): 5957-5962.
  16. Veena M, Sushila K, Lata R, Devendra B, Amrawatin K, Kalpana B. An observational cross sectional study of serum anti-mullerian hormone in PCOS infertile women. Int J Sci Res Manage 2016;4(6):4253-4261.
  17. Begawy AF, El-Mazny AN, Abau-Salem NA, El Taweel NE. AMH in polycystic ovary syndrome and normo-ovulatory women: correlation with clinical hormonal and ultrasonographic parameters. Middle East Fertil Soc J 2010;15(4): 253-258.
  18. You SY, Park SY, Yang GY, Jeong KA, Kim YJ, Chung HW. Anti-mullerian hormone in women with polycystic ovary syndrome. Korean J Obstet Gynecol 2012;55:315-324.
  19. Hann LE, Hall DA, McArdle CR, Seibel M. Polycystic ovarian disease: sonographic spectrum. Radiology 1984;150:531-534.
  20. Esmaeilzadeh S, Andarieh MG, Ghandimi R, Delavar MA. Body mass index and gonadotropin hormones (LH and FSH) associate with clinical symptoms among women with polycystic ovary syndrome. Global J Health Sci 2015 Mar;7(2):101-106.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.